Projects per year
Personal profile
Headline
Biography
Fingerprint
- 1 Similar Profiles
Network
Projects
- 1 Active
-
Characterizing and predicting colitis in immune checkpoint blockade-treated cancer patients
Gnjatic, S., Colombel, J., Faith, J., Gnjatic, S., Colombel, J. J. & Faith, J. J. J.
National Institute of Diabetes and Digestive and Kidney Diseases
1/06/20 → 31/05/23
Project: Research
-
Gender-Based Differences in Response to Tumor Necrosis Factor Inhibitor Therapies for Ulcerative Colitis: Individual Participant Data Meta-Analyses of Clinical Trials
Agrawal, M., Petralia, F., Tepler, A., Durbin, L., Reinisch, W., Colombel, J. F. & Shah, S. C., 5 Jan 2023, In: Inflammatory Bowel Diseases. 29, 1, p. 1-8 8 p.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
Inflammatory Bowel Disease Is Associated With Prediagnostic Perturbances in Metabolic Pathways
Nurses’ Health Study & PREDICTS Collaborators, Jan 2023, In: Gastroenterology. 164, 1, p. 147-150.e2Research output: Contribution to journal › Short survey › peer-review
Open Access -
Aging and IBD: A New Challenge for Clinicians and Researchers
Faye, A. S. & Colombel, J. F., 1 Jan 2022, In: Inflammatory Bowel Diseases. 28, 1, p. 126-132 7 p.Research output: Contribution to journal › Article › peer-review
9 Scopus citations -
An overview of ozanimod as a therapeutic option for adults with moderate-to-severe active ulcerative colitis
Rowan, C., Ungaro, R., Mehandru, S. & Colombel, J. F., 2022, In: Expert Opinion on Pharmacotherapy. 23, 8, p. 893-904 12 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
A Review of the Totality of Evidence for the Development and Approval of ABP 710 (AVSOLA), an Infliximab Biosimilar
Reinisch, W., Cohen, S., Ramchandani, M., Khraishi, M., Liu, J., Chow, V., Franklin, J. & Colombel, J. F., Jan 2022, In: Advances in Therapy. 39, 1, p. 44-57 14 p.Research output: Contribution to journal › Review article › peer-review
Open Access
Press / Media
-
Long-term Safety of Vedolizumab for Inflammatory Bowel Disease
Bruce E. Sands & Jean-Frédéric Colombel
26/10/20
1 item of Media coverage
Press/Media
-
-
Tofacitinib Maintenance Dose for Patients With UC
Bruce E. Sands & Jean-Frédéric Colombel
3/02/20
1 item of Media coverage
Press/Media
-
Kenneth Rainin Foundation Awards $2.6 Million for Cutting-Edge IBD Research
2/10/18 → 3/10/18
5 items of Media coverage
Press/Media